Hamblin Phillips
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 7
-
- RNA Interference and Gene Delivery 6
- Sphingolipid Metabolism and Signaling 1
- Co-authors
- James E. Talmadge (13 shared papers)Henry R. Tribble (7 shared papers)Robin Pennington (6 shared papers)Mark Schneider (7 shared papers)Barbara Lenz (6 shared papers)Robert H. Wiltrout (3 shared papers)R Pennington (2 shared papers)Cedric W. Long (3 shared papers)
- Journals
- Cancer Immunology Immunotherapy (2 papers)Journal of Cellular Biochemistry (1 paper)The Journal of Immunology (1 paper)International Journal of Immunopharmacology (1 paper)Lipids (1 paper)
- Partner nations
- United StatesNetherlands
In The Last Decade
Hamblin Phillips
13 papers receiving 549 citations
Peers
Comparison fields: 5 of 71
- Immunology 328
- Oncology 196
- Immunology and Allergy 23
- Toxicology 12
- Biotechnology 27
Countries citing papers authored by Hamblin Phillips
This map shows the geographic impact of Hamblin Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamblin Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamblin Phillips more than expected).
Fields of papers citing papers by Hamblin Phillips
This network shows the impact of papers produced by Hamblin Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamblin Phillips. The network helps show where Hamblin Phillips may publish in the future.
Co-authors
The 18 scholars most cited alongside Hamblin Phillips, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immunomodulatory properties of recombinant murine and human tumor necrosis factor. | 1988 | 119 |
| 2 | Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice. | 1987 | 110 |
| 3 | Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease. | 1987 | 81 |
| 4 | Immunomodulatory and therapeutic properties of bestatin in mice. | 1986 | 74 |
| 5 | Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose. | 1985 | 42 |
| 6 | 1985 | 36 | |
| 7 | Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose. | 1985 | 27 |
| 8 | 1987 | 20 | |
| 9 | Preclinical approaches to the treatment of metastatic disease: therapeutic properties of rH TNF, rM IFN-gamma, and rH IL-2. | 1987 | 14 |
| 10 | 1992 | 13 | |
| 11 | 1989 | 12 | |
| 12 | 1988 | 8 | |
| 13 | 1993 | 7 |
About Hamblin Phillips
Hamblin Phillips is a scholar working on Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Organic Chemistry and Oncology, having authored 13 papers that have together received 563 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers), RNA Interference and Gene Delivery (6 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Cytokine Signaling Pathways and Interactions (1 paper), Sphingolipid Metabolism and Signaling (1 paper) and Microbial Natural Products and Biosynthesis (1 paper). The work is most often cited by research in Immunology (328 citations), Oncology (196 citations), Immunology and Allergy (23 citations), Toxicology (12 citations) and Biotechnology (27 citations). Hamblin Phillips has collaborated with scholars based in United States and Netherlands. Frequent co-authors include James E. Talmadge, Henry R. Tribble, Robin Pennington, Mark Schneider, Barbara Lenz, Robert H. Wiltrout, R Pennington, Cedric W. Long, John Schindler and Margaret S. Collins. Their work appears in journals such as Cancer Immunology Immunotherapy, Journal of Cellular Biochemistry, The Journal of Immunology, International Journal of Immunopharmacology and Lipids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.